Nerviano Medical Sciences
Clinical trials sponsored by Nerviano Medical Sciences, explained in plain language.
-
New hope for tough leukemia: experimental drug targets resistant cancers
Disease control Recruiting nowThis early-stage study tests an experimental drug called NMS-03597812 in about 124 adults whose acute myeloid leukemia has returned or not responded to standard treatments, including those with a TP53 gene mutation. The main goals are to check the drug's safety, find the right do…
Phase: PHASE1 • Sponsor: Nerviano Medical Sciences • Aim: Disease control
Last updated May 17, 2026 05:47 UTC
-
New hope for recurrent ovarian cancer: targeted drug combo enters human testing
Disease control Recruiting nowThis early-stage study tests a new experimental drug (NMS-03305293) combined with a standard chemotherapy (topotecan) in 24 people whose ovarian cancer has returned after prior treatments. The main goals are to check safety and find the best dose, while also seeing if the combina…
Phase: PHASE1 • Sponsor: Nerviano Medical Sciences • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New hope for hard-to-treat lung cancer? early trial launches
Disease control Recruiting nowThis early-stage study tests a new targeted drug (NMS-03305293) combined with chemotherapy (temozolomide) in people with small cell lung cancer that has returned after prior treatments. The main goals are to check safety and find the right dose. About 10 participants will be enro…
Phase: PHASE1 • Sponsor: Nerviano Medical Sciences • Aim: Disease control
Last updated May 11, 2026 20:41 UTC